spot_img
Monday, September 26, 2022
More
    HomeHealthA CRISPR treatment for blood diseases continues to benefit patients

    A CRISPR treatment for blood diseases continues to benefit patients

    -



    Updated outcomes introduced Saturday from two scientific trials involving an experimental, genome-editing therapy confirmed extended profit for sufferers born with inherited blood issues sickle cell illness and beta-thalassemia.

    Seventy-five sufferers have now been handled with the remedy developed collectively by Vertex Prescribed drugs and CRISPR Therapeutics that makes use of CRISPR know-how to genetically repair diseased cells. Following a one-time infusion, all 31 of the sufferers with sickle cell reported being free from episodes of extreme ache; 42 of the 44 sufferers with beta-thalassemia not required blood transfusions.

    Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!

    GET STARTED





    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,505FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts